Oxaloplatino [Spanish] en es it fr

Categoria

Oxaloplatino [Spanish] Marchi, Oxaloplatino [Spanish] Analoghi

Oxaloplatino [Spanish] Marchi miscela

  • No information avaliable
  • Oxaloplatino [Spanish] Formula chimica

    C8H12N2O4Pt

    Oxaloplatino [Spanish] RX link

    http://www.rxlist.com/cgi/generic/eloxatin.htm

    Oxaloplatino [Spanish] FDA foglio

    Oxaloplatino_[Spanish] FDA

    Oxaloplatino [Spanish] DMS (foglio di materiale di sicurezza)

    Oxaloplatino_[Spanish] MSDS

    Oxaloplatino [Spanish] Sintesi di riferimento

    Nessuna informazione disponibile

    Oxaloplatino [Spanish] Peso molecolare

    395.27 g/mol

    Oxaloplatino [Spanish] Temperatura di fusione

    No information avaliable

    Oxaloplatino [Spanish] H2O Solubilita

    Nessuna informazione disponibile

    Oxaloplatino [Spanish] Stato

    Solid

    Oxaloplatino [Spanish] LogP

    No information avaliable

    Oxaloplatino [Spanish] Forme di dosaggio

    Nessuna informazione disponibile

    Oxaloplatino [Spanish] Indicazione

    Per il trattamento di neoplasie maligne del colon, del retto e dell'ovaio

    Oxaloplatino [Spanish] Farmacologia

    Oxaliplatino inibisce selettivamente la sintesi di acido desossiribonucleico (DNA). Il contenuto di guanina e citosina correla con il grado di oxaliplatino indotta cross-linking. Ad alte concentrazioni del farmaco, RNA cellulare e la sintesi proteica sono anche soppressi.

    Oxaloplatino [Spanish] Assorbimento

    Nessuna informazione disponibile

    Oxaloplatino [Spanish] Tossicita

    Nessuna informazione disponibile

    Oxaloplatino [Spanish] Informazioni paziente

    Patients and patientsí caregivers should be informed of the expected side effects of ELOXATIN, particularly its neurologic effects, both the acute, reversible effects, and the persistent neurosensory toxicity. Patients should be informed that the acute neurosensory toxicity may be precipitated or exacerbated by exposure to cold or cold objects. Patients should be instructed to avoid cold drinks, use of ice, and should cover exposed skin prior to exposure to cold temperature or cold objects.

    Patients must be adequately informed of the risk of low blood cell counts and instructed to contact their physician immediately should fever, particularly if associated with persistent diarrhea, or evidence of infection develop.

    Patients should be instructed to contact their physician if persistent vomiting, diarrhea, signs of dehydration, cough or breathing difficulties occur, or signs of allergic reaction appear.

    Oxaloplatino [Spanish] Atto interessato organismi

    Gli esseri umani e altri mammiferi